Search

Your search keyword '"Cecilia Camacho-Hübner"' showing total 310 results

Search Constraints

Start Over You searched for: Author "Cecilia Camacho-Hübner" Remove constraint Author: "Cecilia Camacho-Hübner"
310 results on '"Cecilia Camacho-Hübner"'

Search Results

1. Adult height prediction by bone age determination in children with isolated growth hormone deficiency

2. The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis

3. Pituitary function and the response to GH therapy in patients with Langerhans cell histiocytosis: analysis of the KIMS database

4. Adult height prediction by bone age determination in children with isolated growth hormone deficiency

5. Near-Adult Height After Growth Hormone Treatment in Children Born Prematurely—Data From KIGS

6. More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY

7. Response to GH Treatment After Radiation Therapy Depends on Location of Irradiation

8. Targeted literature review of the humanistic and economic burden of adult growth hormone deficiency

9. Racial/Ethnic Disparities in US Pediatric Growth Hormone Treatment

10. Long-term treatment with pegvisomant: Observations from 2090 acromegaly patients in ACROSTUDY

11. New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis

12. Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement

13. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database

14. SUN-LB080 ACROSTUDY - Safety and Efficacy of a Cohort of 110 Naïve Patients with Acromegaly Treated with Pegvisomant

15. SAT-444 Pituitary Function and the Response to GH Replacement Therapy in Patients with Histiocytosis: Analysis of the Pfizer International Metabolic Database (KIMS)

16. SUN-LB079 Acrostudy - Safety And Treatment Outcomes In 2221 Patients With Acromegaly Treated With Pegvisomant: Real World Experience

17. Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy

18. Improvements in Body Composition after 4 Years of Growth Hormone Treatment in Adult-Onset Hypopituitarism Compared to Age-Matched Controls

19. Safety and Efficacy of Pegvisomant in Pediatric Growth Hormone Excess

20. Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model.

21. Weight gain in Turner Syndrome: association to puberty induction? - longitudinal analysis of KIGS data

22. Treatment with Growth Hormone in Noonan Syndrome Observed during 25 Years of KIGS: Near Adult Height and Outcome Prediction

23. Near Adult Height in Girls with Turner Syndrome Treated with Growth Hormone Following Either Induced or Spontaneous Puberty

24. The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis

25. Secular Trends on Birth Parameters, Growth, and Pubertal Timing in Girls with Turner Syndrome

26. Efficacy of Growth Hormone Treatment in Children with Type 1 Diabetes Mellitus and Growth Hormone Deficiency-An Analysis of KIGS Data

29. Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormone

30. Radiotherapy, Especially at Young Age, Increases the Risk for De Novo Brain Tumors in Patients Treated for Pituitary/Sellar Lesions

31. Combined Treatment With GH and IGF-I: Additive Effect on Cortical Bone Mass But Not on Linear Bone Growth in Female Rats

32. Juvenile rheumatoid arthritis. Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin

33. Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly

34. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults

35. Baseline Characteristics and Gender Differences in Prepubertal Children Treated with Growth Hormone in Europe, USA, and Japan: 25 Years' KIGS® Experience (1987-2012) and Review

36. Individualised Growth Response Optimisation (IGRO): A Multi-Language Software Medical Device to Predict Growth Response in Children Treated With Growth Hormone (GH)

37. Evidence for a Continuum of Genetic, Phenotypic, and Biochemical Abnormalities in Children with Growth Hormone Insensitivity

38. Human Acid-Labile Subunit Deficiency: Clinical, Endocrine and Metabolic Consequences

39. Abnormal Growth in Noonan Syndrome: Genetic and Endocrine Features and Optimal Treatment

40. Changes in protein turnover, IGF-I and IGF binding proteins in children with cancer

41. Growth Hormone Insensitivity and Severe Short Stature in Siblings: A Novel Mutation at the Exon 13-Intron 13 Junction of the STAT5b Gene

42. Postnatally Elevated Levels of Insulin-Like Growth Factor (IGF)-II Fail to Rescue the Dwarfism of IGF-I-Deficient Mice except Kidney Weight

44. Pregnancy in acromegaly patients treated with pegvisomant

45. An Intronic Growth Hormone Receptor Mutation Causing Activation of a Pseudoexon Is Associated with a Broad Spectrum of Growth Hormone Insensitivity Phenotypes

46. Final Height in Patients with Idiopathic Short Stature and High Growth Hormone Responses to Stimulation Tests

47. Dehydroepiandrosterone Improves Psychological Well-Being in Male and Female Hypopituitary Patients on Maintenance Growth Hormone Replacement

48. Diagnostic and Therapeutic Advances in Growth Hormone Insensitivity

49. Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature

50. Relationships between Serum IGF-1, IGFBP-2, Interleukin-1Beta and Interleukin-6 in Inflammatory Bowel Disease

Catalog

Books, media, physical & digital resources